5-138274421-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001496.4(GFRA3):c.4G>A(p.Val2Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000306 in 1,306,114 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001496.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GFRA3 | NM_001496.4 | c.4G>A | p.Val2Met | missense_variant | 1/8 | ENST00000274721.8 | NP_001487.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GFRA3 | ENST00000274721.8 | c.4G>A | p.Val2Met | missense_variant | 1/8 | 1 | NM_001496.4 | ENSP00000274721 | P2 | |
GFRA3 | ENST00000378362.3 | c.4G>A | p.Val2Met | missense_variant | 1/7 | 1 | ENSP00000367613 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152242Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000260 AC: 3AN: 1153872Hom.: 0 Cov.: 31 AF XY: 0.00000360 AC XY: 2AN XY: 555544
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152242Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74384
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 15, 2023 | The c.4G>A (p.V2M) alteration is located in exon 1 (coding exon 1) of the GFRA3 gene. This alteration results from a G to A substitution at nucleotide position 4, causing the valine (V) at amino acid position 2 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at